Compounded Testosterone for Men: Delivery Forms, Dosing, and How to Choose in 2026

Introduction: Why Compounded Testosterone Is Reshaping Men’s Hormonal Health in 2026

The numbers tell a striking story. Testosterone prescriptions in the United States climbed from 7.3 million in 2019 to more than 11 million by 2024, driven in part by the natural decline that begins in a man’s mid-30s at roughly 1.6% per year. What was once considered a concern reserved for older men has become a far broader conversation.

Yet a paradox sits at the center of this trend. A large U.S. insurance database study found that hypogonadism prevalence rose from 0.78% to 5.4% over the study period, while treatment rates actually fell from 32.9% to 20.8%. More men qualify for treatment than ever before, yet fewer are receiving it. That is a significant and growing treatment gap.

The relevance extends well beyond the traditional 50-plus demographic. Research documented a 25.5% decline in testosterone levels among men aged 15 to 39 between 2000 and 2016, helping explain why younger men are increasingly seeking therapy.

The core problem with commercial testosterone replacement therapy (TRT) is rigidity: fixed concentrations, a limited menu of delivery options, and no ability to accommodate individual dosing needs, allergies, or fertility goals. Compounded testosterone offers a clinical alternative, with custom dosages, multiple delivery forms, allergen-free formulations, and direct pharmacist-prescriber collaboration making individualized therapy possible.

This article is not a generic overview. It is a clinical decision framework that maps each delivery form to its pharmacokinetics, lifestyle fit, and patient goals. Throughout, the quality benchmarks held by pharmacies like Nationwide Compounding Rx, including PCAB accreditation, USP 800 compliance, and FDA-inspected sourcing, serve as the standard readers should expect from any compounding partner.

What Is Compounded Testosterone and How Does It Differ from Commercial TRT?

Compounded testosterone is a custom-prepared medication formulated by a licensed compounding pharmacy to meet individual patient needs that mass-manufactured products cannot address.

Commercial options such as AndroGel, Testim, and KYZATREX come in fixed concentrations and a narrow range of delivery forms. They offer no flexibility to remove allergens or inactive ingredients and no path to precise dose titration.

Compounding changes that equation. Its key clinical advantages include:

• Personalized dose titration based on lab results
• Multiple delivery formats from a single pharmacy
• Elimination of common allergens such as lactose, dyes, and gluten
• The ability to replicate discontinued formulations

On regulatory status, compounded testosterone is not FDA-approved as a finished drug product, but it is legally prepared under federal and state pharmacy law. A critical quality distinction exists between 503A pharmacies and 503B outsourcing facilities, expanded in a later section. Regardless of how it is prepared, testosterone remains a Schedule III controlled substance under DEA oversight.

Before any therapy begins, diagnosis matters. The American Urological Association (AUA) defines testosterone deficiency as total serum testosterone below 300 ng/dL on two separate morning samples, with both biochemical and symptomatic confirmation required.

The Regulatory Landscape for Compounded Testosterone in 2026

The regulatory picture has shifted meaningfully in recent years. On February 28, 2025, the FDA issued class-wide labeling changes for all testosterone products following the landmark TRAVERSE trial of 5,246 men aged 45 to 80. The changes removed the boxed cardiovascular warning and added a new blood pressure monitoring requirement.

Momentum has continued. The FDA convened an expert panel on December 10, 2025 to discuss expanding TRT indications, and in April 2026 the agency invited NDA holders to seek approval for new indications including idiopathic hypogonadism and low libido. This signals a maturing regulatory environment.

On access, testosterone can currently be prescribed via telehealth without a prior in-person visit under a DEA/HHS flexibility window running through December 31, 2026, with uncertainty beyond that date.

A core structural distinction shapes quality oversight. 503A compounding pharmacies are primarily regulated by state boards of pharmacy, while 503B outsourcing facilities fall under FDA oversight and CGMP standards (NCBI Bookshelf). Because 503A oversight is less centralized, accreditation credentials like PCAB become especially important as a proxy for quality. Nationwide Compounding Rx holds PCAB accreditation, operates a USP 800 compliant facility, and sources all active pharmaceutical ingredients exclusively from FDA-inspected and cleared vendors.

503A vs. 503B: Why the Pharmacy’s Accreditation Status Matters More Than You Think

503A pharmacies prepare medications on a patient-specific, prescription-by-prescription basis and are regulated primarily by state boards of pharmacy. 503B outsourcing facilities operate at larger scale, can compound without patient-specific prescriptions, and must register with the FDA while meeting CGMP standards.

The practical concern is that FDA oversight of 503A pharmacies is limited, so quality can vary significantly from one pharmacy to the next. Third-party accreditation fills that gap.

• PCAB accreditation is the gold standard for 503A pharmacies. The Pharmacy Compounding Accreditation Board references U.S. Pharmacopeial Convention guidelines and independently assesses safety and quality compliance.
• USP 800 compliance governs the handling of hazardous drugs, including hormones like testosterone, and eliminates cross-contamination risks. Not all pharmacies meet this standard.
• FDA-inspected vendor sourcing is an upstream quality control step that many pharmacies do not explicitly verify.

When evaluating a compounding pharmacy, patients should ask specifically about PCAB accreditation, USP 800 compliance, and API sourcing, not just state licensure. Nationwide Compounding Rx voluntarily meets all three benchmarks, backed by 40 years of combined staff experience and a 1 to 2 business day turnaround.

Compounded Testosterone Delivery Forms: A Pharmacokinetic Comparison

Pharmacokinetics (PK) describes how quickly testosterone enters the bloodstream, how long it stays active, and how consistently levels are maintained.

These differences are clinically meaningful. Peak-to-trough variability affects symptom control, mood stability, libido, energy, and side effect risk. The sections below form the foundation for the lifestyle-matching framework that follows. Every delivery form discussed is available as a compounded preparation, allowing dose customization that commercial products cannot match.

Intramuscular (IM) Injections

Testosterone, typically cypionate or enanthate, is injected into muscle tissue (gluteal, vastus lateralis, or deltoid), forming a depot that releases slowly into the bloodstream.

PK profile: Peak serum levels typically occur within 24 to 72 hours; trough levels are reached by day 7 to 14 depending on ester and dose. Weekly or biweekly dosing produces a wide peak-to-trough swing.

Compounding advantage: Custom concentrations and carrier oils such as grape seed oil support both IM and SubQ administration and reduce injection site reactions common with cottonseed oil.

Cost: The most cost-effective form at roughly $30 to $75 per month.

Ideal patient: Men comfortable with self-injection, those prioritizing cost, and those who prefer less frequent dosing.

Considerations: Peak-to-trough swings can cause mood fluctuations; injection technique training is needed; not ideal for men with needle aversion or certain bleeding disorders.

Subcutaneous (SubQ) Injections

A smaller-gauge needle delivers testosterone into subcutaneous fat (abdomen or thigh), creating a slower-release depot than IM.

PK profile: Slower absorption means lower peaks and reduced peak-to-trough variability, with more stable concentrations when dosed more frequently (often twice weekly). A 2025 review confirmed SubQ as a validated alternative with improved pharmacokinetics and better adherence.

Compounding advantage: Grape seed oil formulations are optimized for SubQ use, and lower injection volumes reduce discomfort.

Ideal patient: Men wanting smoother hormone levels, those who find IM painful, and those prioritizing mood and energy stability.

Considerations: More frequent injections (typically twice weekly); site rotation prevents lipohypertrophy.

Transdermal Creams

Testosterone is absorbed through the skin, with absorption and DHT conversion varying by application site.

Scrotal advantage: Scrotal skin has far higher permeability than other sites. Application to the scrotum or inner thigh produces higher DHT conversion, which some men find beneficial for libido and energy.

PK profile: Daily application produces relatively stable levels, peaking within 2 to 8 hours, without the sharp swings of weekly injections.

Compounding advantage: Commercial gels are fixed at 1 to 2%. Compounded creams can be formulated 10 to 20 times more concentrated, allowing effective dosing in much smaller volumes.

Absorption variability: Skin permeability, body fat, application site, and hydration all affect absorption, making lab monitoring essential.

Transfer risk: Skin-to-skin contact can transfer testosterone to partners or children; proper application and covering the site mitigate this risk.

Ideal patient: Needle-averse men, those who prefer a daily routine, those seeking higher DHT conversion, and those needing precise titration.

Subcutaneous Pellets

Small crystalline pellets (12.5 mg to 200 mg each) are implanted subcutaneously, usually in the hip or buttock, under local anesthesia. They dissolve slowly over 3 to 6 months.

PK profile: This form produces the most stable, consistent serum levels of any delivery method, with no daily or weekly administration required. Levels gradually decline as pellets dissolve.

Compounding advantage: Dose is fully customizable based on patient weight, baseline endocrine profile, and target trough, an individualization impossible with commercial products.

Market context: A 2025 PMC critical review cautioned that indiscriminate use of compounded pellets has been linked to increased adverse effects, making proper patient selection essential.

Ideal patient: Men prioritizing convenience and freedom from frequent dosing, those with stable hormone profiles, and frequent travelers.

Considerations: A minor surgical procedure is required every 3 to 6 months; the dose cannot be adjusted or removed once implanted; a certified practitioner is required; not suitable for men needing frequent dose adjustment.

Oral Testosterone Capsules

Compounded oral testosterone (typically undecanoate or enanthate) is absorbed via the lymphatic system, bypassing first-pass hepatic metabolism when formulated correctly.

PK profile: Twice-daily dosing produces moderate fluctuations, peaking roughly 4 to 6 hours post-dose. Levels are less stable than with creams or pellets but more convenient than injections for needle-averse men.

Compounding advantage: Branded oral testosterone (KYZATREX) costs $400 to $700 per month without insurance; compounded capsules run $100 to $250 per month with equivalent active ingredient.

Considerations: Must be taken with a fat-containing meal for optimal absorption; twice-daily adherence is required; blood pressure monitoring is required per the 2025 FDA labeling change.

Choosing the Right Delivery Form: A Lifestyle-Based Decision Framework

Delivery form selection should be driven by four intersecting factors: pharmacokinetic goals, lifestyle and administration preferences, fertility status, and individual absorption characteristics.

No single form is universally superior. The best choice is the one that aligns with a man’s clinical profile and his real-world adherence potential. A prescriber and compounding pharmacist should always guide the final decision, with titration based on regular lab monitoring.

Matching Delivery Form to Lifestyle Profile

• The frequent traveler or busy professional: Pellets offer the greatest convenience (one procedure every 3 to 6 months). Oral capsules are a portable secondary option.
• The needle-averse man: Transdermal creams or oral capsules eliminate injections; scrotal cream may suit those seeking higher DHT conversion.
• The cost-conscious patient: Compounded IM or SubQ injections at $30 to $75 per month are most affordable; oral capsules at $100 to $250 per month come next.
• The man prioritizing stability and mood consistency: Twice-weekly SubQ injections or daily creams produce the smoothest hormone curves; pellets offer the most stable long-term levels.
• The man with skin sensitivities or transfer concerns: Injections or oral capsules avoid transdermal application entirely.
• The man with an active fitness routine: Injections allow precise timing around training; pellets provide consistent baseline levels.

Fertility Goals: The Critical Variable That Changes Everything

This is a decision point, not a footnote. TRT suppresses natural testosterone production in the testes by up to 94%, significantly reducing sperm production regardless of delivery form. The AUA recommends against prescribing testosterone to men who desire current or future fertility.

Two compounded options preserve fertility:

• Compounded HCG mimics LH, stimulating intratesticular testosterone production and maintaining spermatogenesis. Studies show it can preserve sperm parameters during TRT.
• Compounded enclomiphene citrate, a SERM, stimulates the hypothalamic-pituitary axis to boost endogenous testosterone without suppressing fertility. It is not FDA-approved as a standalone drug but is available through compounding pharmacies, and it is particularly relevant given the 58% increase in TRT prescriptions for men aged 35 to 44.

Men under 40, or anyone with future fertility intent, should have an explicit fertility preservation conversation before selecting a delivery form. Fertility status should be established first, not afterward.

Absorption Variability and Individual Factors That Affect Delivery Form Performance

Individual PK response varies based on body composition, age, metabolic rate, skin permeability, and injection technique.

• Transdermal: Higher body fat or thicker skin can reduce absorption; scrotal application consistently outperforms other sites.
• Injection depots: Body fat distribution affects depot formation; very lean men may absorb faster with a shorter duration of effect.
• Oral bioavailability: Meal fat content directly affects lymphatic absorption; inconsistent meals produce variable levels.
• Pellet dissolution: Activity level, vascularity at the site, and metabolic rate influence dissolution speed; some men require more frequent reimplantation.

The practical implication is clear: lab monitoring at 3 and 6 months is not optional. It is how dose and delivery form are validated for the individual. Compounded formulations allow adjustments at each refill based on lab results, a clinical advantage commercial products cannot match.

Safety Monitoring: What Every Man on Compounded TRT Must Track

Safety monitoring is non-negotiable, reinforced by the February 2025 FDA labeling changes that added a mandatory blood pressure requirement. Key parameters include:

• Hematocrit and hemoglobin: TRT stimulates red blood cell production; elevated hematocrit (polycythemia) raises clotting and stroke risk. Monitor at 3 and 6 months, then annually.
• PSA: Baseline and follow-up monitoring is standard; TRT is contraindicated in men with known or suspected prostate cancer.
• Blood pressure: A new FDA requirement, especially relevant for oral formulations.
• Estradiol (E2): Testosterone aromatizes to estradiol; elevation can cause gynecomastia, water retention, and mood changes, guiding aromatase inhibitor use.
• Lipid panel: TRT can affect HDL and LDL; baseline and periodic monitoring are recommended.
• Serum testosterone (total and free): Confirms target levels and guides dose adjustments.
• LH and FSH: For men on fertility protocols, these confirm suppression status and guide HCG or enclomiphene dosing.

A typical monitoring schedule runs labs at 3 months, then 6 months, then annually if stable. Monitoring labs typically cost $150 to $300 per quarter, a figure that belongs in any TRT budget.

What to Look for in a Compounding Pharmacy for Testosterone

A compounded medication is only as good as the pharmacy preparing it, and standards vary across the industry. Five credentials matter most:

1. PCAB Accreditation: Independent assessment against U.S. Pharmacopeial Convention guidelines, exceeding state licensure alone.
2. USP 800 Compliance: Governs safe handling of hazardous drugs and eliminates cross-contamination risks affecting potency and purity.
3. FDA-Inspected API Sourcing: Active ingredients sourced exclusively from high quality chemicals from FDA-inspected and cleared vendors.
4. Prescriber Collaboration: A quality pharmacy customizes formulations based on individual lab results rather than filling prescriptions without clinical context.
5. Turnaround and Shipping Reach: Reliable 1 to 2 business day turnaround and broad shipping coverage are practical quality-of-care factors.

Nationwide Compounding Rx meets all five: PCAB-accredited, USP 800 compliant, sourcing API exclusively from FDA-inspected vendors, operating a collaborative prescriber model, offering 1 to 2 business day turnaround, and shipping to 47 states plus Washington, D.C. The pharmacy does not currently serve Alabama, California, North Carolina, or South Carolina. Reach the team toll-free at 1-833-650-9836, online at NationwideCompounding.com, or locally at 480-499-8379 in Scottsdale, AZ.

Compounded Testosterone Cost Overview: Setting Realistic Expectations

A clear cost comparison by delivery form helps set expectations:

• Compounded IM/SubQ injections: $30 to $75 per month, the most cost-effective option.
• Compounded transdermal creams: $50 to $150 per month depending on concentration and volume.
• Compounded oral capsules: $100 to $250 per month, well below branded KYZATREX at $400 to $700 per month.
• Compounded pellets: Material cost is typically bundled with the procedure fee.
• All-in telehealth platforms: $150 to $300 per month for compounded options; traditional clinics run $350 to $900 per month with separate fees.

The costs most comparisons omit include lab monitoring ($150 to $300 per quarter), estrogen management add-ons ($20 to $60 per month if an aromatase inhibitor is needed), and fertility preservation protocols (compounded HCG or enclomiphene can add $500 to $1,500 upfront). Cost should be evaluated as total treatment cost, not medication cost alone. Pricing for compounded medications requires a prescription and prescriber consultation; Nationwide Compounding Rx works directly with providers to customize formulations and pricing.

Conclusion: A Personalized Framework for a Personalized Treatment

Compounded testosterone offers a clinically superior level of personalization compared to commercial TRT, but only when the delivery form is matched to the individual’s pharmacokinetic needs, lifestyle, fertility goals, and absorption profile.

The decision hierarchy is straightforward: injections for cost-effectiveness and dose control, transdermal creams for needle aversion and DHT optimization, pellets for maximum convenience and hormonal stability, and oral capsules for discreet, needle-free administration.

For any man under 40, or with future fertility intent, delivery form selection must follow a fertility preservation conversation, with compounded HCG or enclomiphene as established options. The value of compounded testosterone is only fully realized when it is prepared by a pharmacy with verifiable credentials: PCAB accreditation, USP 800 compliance, and FDA-inspected API sourcing.

The evolving regulatory landscape, including the April 2026 FDA signals on expanded indications, reflects a clinical environment increasingly validating individualized testosterone therapy. Men who understand these pharmacokinetic differences, ask the right questions, and commit to ongoing lab monitoring are best positioned for consistent, safe, and effective results.

Ready to Explore Compounded Testosterone? Work with a Pharmacy That Meets the Standard

If a prescriber has recommended compounded testosterone therapy, the pharmacy chosen matters as much as the delivery form selected.

Nationwide Compounding Rx is PCAB-accredited, USP 800 compliant, sources API exclusively from FDA-inspected vendors, brings 40 years of combined staff experience, offers 1 to 2 business day turnaround, and ships to 47 states plus Washington, D.C. The team works directly with healthcare providers to customize testosterone formulations, including injections, transdermal creams, and oral capsules, based on individual lab results and clinical goals. Learn more about our men’s health compounding services and how we support individualized testosterone therapy.

To get started, call toll-free at 1-833-650-9836, visit NationwideCompounding.com, or fax prescriptions to 480-699-5341. Office hours are Monday through Friday, 7:00 a.m. to 3:30 p.m.

Compounded testosterone requires a valid prescription from a licensed healthcare provider. This article is for informational purposes and does not constitute medical advice. Residents of Alabama, California, North Carolina, and South Carolina should note that Nationwide Compounding Rx is currently unable to ship to those locations and should consult their prescriber for alternative options.